Hemostemix Announces the Appointment of Dr. Terry Hébert, PhD, to its Scientific Advisory Board Read More
Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments Read More
Hemostemix Announces Dr. Giannetti and Dr. Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials Read More
HEMOSTEMIX ANNOUNCES THE FIRST TRANCHE CLOSING OF $1.8M OF ITS RECENTLY ANNOUNCED PRIVATE PLACEMENT Read More
Hemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant Applications Read More
